Global Drugs of Abuse Testing Market: Snapshot
According to the United Nations Office on Drugs and Crime, nearly five percent of the global adult population consumed some sort of prohibited drug at least once in 2015. That percentage escalates steeply if we consider it within the U.S., a country that has been marred by the cases of substance abuse for several decades. Similar incrementing numbers are being observed in European nations too and as a result, resilient measures are now being undertaken by respective governments to overcome this cause of premature death among the adults. Consequently, the global drugs of abuse testing market is flourishing, with the demand projected to expand at a notable CAGR of 5.4% during the forecast period of 2017 to 2025. The analysts of the report have evaluated that there were opportunities worth US$4,443.9 mn in the global drugs of abuse testing market in 2017. By the end of the aforementioned forecast period, 2025, the valuation of the market is estimated to swell up to US$6,781.6 mn.
Obtain Report Details @
The market for drugs of abuse testing, which can be an in-house or onsite examination of drugs within a human body, is gaining traction from a number of factors such as advancements in technology of analyzers, increasing availability of forbidden drugs, and growing emphasis on work place screening among the urban populations. The advent of testing devices that are overcoming the need for a sample of saliva, urine, or blood to be taken to a laboratory is foreseen as a major boon for the drugs of abuse testing market. On the other hand, lack of awareness regarding the availability of advanced drug testing devices and its consideration as a violation of privacy rights in some countries are a few restraints hampering the growth of the market.
Request Report Brochure @
Consumables Provide for the Major Chunk of Overall Demand
On the basis of product type, the drugs of abuse testing market has been segmented into three major sub segments of analyzers, rapid testing devices, and consumables. Between these segments, consumables accounted for around 35.7% market share (in terms of revenue), in 2016. One of the most common and beneficial uses of consumables is that it is used in every application for taking the sample. The segment of consumables includes fluid collection devices and rest all other reagents used in carrying out the laboratory test. The rapid testing devices are most convenient devices for carrying out the preliminary test for detection of drug in the human body owing to its portability. The test conducted using rapid testing devices usually denoted positive or negative results. If further detailed investigation is required then the testing are done in the laboratories using the analyzers.